Monday marked a tremendous milestone for our partner CSL, with the official opening of their new Global Headquarters and Centre for Research and Development.
655 Elizabeth Street was officially opened by Prime Minister of Australia, the Honourable Anthony Albanese MP alongside CSL’s Chairperson Brian McNamee, CEO Paul McKenzie, and Chief Financial Officer Joy Linton in a formal celebration held within the stunning lobby of our landmark Elizabeth North development.
A beacon for Australian biomedical research and innovation, our 54,000 sqm 18-storey building features nine floors of state-of-the-art laboratories and cutting-edge research and clinical phase production suites that are meaningfully integrated with seven floors of versatile workspace designed to promote connectivity, amenity, and well-being.
The site will enhance CSL’s collaborative potential with external partners, providing access to optimal resources to strengthen development initiatives and harness technological advancements.
‘This magnificent facility will help position CSL to compete in the global marketplace,’ said the Prime Minister. ‘The work that CSL does right here will continue to be integral to Australian’s health and quality of life.’
CSL Chairperson Brian McNamee added, ‘This very building stands as a testament to our transformative journey from our century old Royal Park site. It is a realm of discovery and development, offering possibilities to Australia’s local researchers and becoming a source of ground-breaking medicines for patients across the globe.’
CSL Chief Financial Officer Joy Linton graciously thanked Vince Giuliano and the PDG team, led by our Development Director Sebastian Mahoney and Project Director Alex Paterson, alongside key partners and stakeholders including Roberts Co, Cox, and Wood for delivering this remarkable outcome.
The successful delivery stands as a testament to the unwavering collaboration between each project team and affiliated consultants: DELWP, Meinhardt, WSP, Biotech Engineering, Urbis, Colliers, Phillip Chun Building Compliance, and local and state government planning authorities.
PDG’s Founder & Managing Director, Vince Giuliano said, ‘Elizabeth North represents PDG’s enduring dedication and commitment to deliver world-class biomedical research facilities and exemplar contemporary workspaces that will contribute significantly to innovative progress in the City of Melbourne.’
‘We are extremely proud to be a part of this new era for CSL which will continue to see their new Global Headquarters and Centre for R&D attract the brightest minds from Australia, and around the world, to work on ground-breaking biomedical developments and advancements right here in the heart of Melbourne’s Biomedical Precinct.’
The wider Elizabeth North Precinct was a result of the State Government and the City of Melbourne’s 10-year strategic plan for the Melbourne Biomedical Precinct. Not only to position the area as a leader in knowledge-based industries but to elevate its global presence.